INGLENMARK Stock Latest News
Company AnnouncementsGlenmark Schedules Q2 FY 2027 Earnings Call for November 61w ago
Company AnnouncementsGlenmark expands U.S. dermatology reach with Adapalene pump-pack launch3w ago- Company AnnouncementsGlenmark Pharma Closes Trading Window Ahead of Q2 FY27 Results1M ago
Company AnnouncementsGlenmark’s Goa Plant Secures U.S. FDA EIR With VAI Status1M ago- Company AnnouncementsGlenmark to Meet Analysts and Investors at Emerging Titans 2026 Conference1M ago
Company AnnouncementsIndia Ratings Lifts Glenmark Pharmaceuticals to ‘IND AA+’ on Stronger Balance Sheet1M agoCompany AnnouncementsGlenmark Enters $70 Million U.S. Calcium Gluconate Market With New Injectables Launch2M ago
- Company AnnouncementsGlenmark Launches Generic Olanzapine Injection in U.S. Institutional Market3M ago
Company AnnouncementsGlenmark Advances Global Phase 3 Trial of Trastuzumab Rezetecan in Ovarian Cancer4M ago
Company AnnouncementsGlenmark to Shift Nebulizer IP to Subsidiary in Strategic Respiratory Push5M ago
Company AnnouncementsGlenmark’s U.S. Unit Reaches $29.6 Million Antitrust Settlement With State Attorneys General5M ago
Company AnnouncementsGlenmark Launches Low-Cost Semaglutide GLIPIQ in India to Expand Diabetes Care7M agoCompany AnnouncementsGlenmark launches low-cost semaglutide GLIPIQ in India to widen diabetes care access7M ago
Company AnnouncementsGlenmark Wins U.S. FDA Nod and 180-Day Exclusivity for Generic FloVent Inhaler8M ago
- Company AnnouncementsGlenmark to Enter $66.8 Million U.S. Sodium Phosphates Injection Market in April8M ago
Company AnnouncementsGlenmark Says GST Department Search Has No Material Impact on Operations9M ago- Company AnnouncementsGlenmark Pharmaceuticals to Launch Ropivacaine Hydrochloride Injection in the USA1y ago
Company AnnouncementsGlenmark Receives FDA Warning for Indore Facility, Ensures No Supply Disruption1y ago
Company AnnouncementsGlenmark Pharmaceuticals Launches Vancomycin Hydrochloride Injection in the US1y ago